Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 193

Sort by

Sort Order Select

Journal Articles

Tumor-Primed CD3 + CD56 + natural Killer T-like Cells As an Efficient Novel Cell Therapy for Relapsed/Refractory Multiple Myeloma

Ji Hyun Lee, Seok-Ho Kim, Junsang Doh, Duck Cho, Jeong-a Kim, Sung Yong Oh, Sung-Hyun Kim, Juheon Lee

Blood (2024) 144 (Supplement 1): 2057.

https://doi.org/10.1182/blood-2024-200559

Published: 2024

Journal Articles

HMGA1 Chromatin Regulators Disrupt 3D Genome Architecture and Chromatin Looping to Repress MHC II Genes and Drive Immune Evasion during MPN Progression

Linda Resar, Joseph Kim, Audrey-Ann Supreme, Hyunsung Woo, Bailey West, Mariah C. Antopia, Zanshe Thompson, Karen Reddy, Jung-Hyun Kim, Leslie Cope, Raajit Rampal, Richard Koche, Alison R. Moliterno, Jerry L. Spivak

Blood (2024) 144 (Supplement 1): 756.

https://doi.org/10.1182/blood-2024-211336

Published: 2024

Journal Articles

Gut Microbiome Composition As a Prognostic Marker in CD19-Targeting CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Seok Jin Kim, SangEun Yoon, Woorim Kang, Mauricio Chalita, Hong Hoe Koo, Dong-Wook Hyun, Hyun Kim, Junhun Cho, Won Seog Kim

Blood (2024) 144 (Supplement 1): 1595.

https://doi.org/10.1182/blood-2024-205074

Published: 2024

Journal Articles

High Mobility Group A1 (HMGA1) Chromatin Regulators Maintain Quiescent, Regenerative HSC By Repressing IGF1 Networks That Promote Stem Cell Aging

Zanshe Thompson, Li Z Luo, Liping Li, Bowen Wang, Jung-Hyun Kim, Lingling Xian, Bailey West, Leslie Cope, John Lister, Linda Resar

Blood (2024) 144 (Supplement 1): 1277.

https://doi.org/10.1182/blood-2024-211649

Published: 2024

Journal Articles

Serial Next-Generation Sequencing for Detection of Germline Predisposition in Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2024-205069

Published: 2024

Journal Articles

The Impact of Multiple Myeloma on Care Partner Well-Being, Work Productivity, and Resource Use in the United States and Western Europe

Kathy Annunziata, Nikoletta Sternbach, Hitomi Tanaka, Marco DiBonaventura, Joseph C. Cappelleri, Jack Watkins, David Hughes, Aster Meche, Chai Hyun Kim, C. Todd Kennedy, Hans Scheurer, Thomas W. LeBlanc

Blood (2024) 144 (Supplement 1): 3762.

https://doi.org/10.1182/blood-2024-201802

Published: 2024

Journal Articles

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

Na Hyun Kim, Fatima Khamissi, Kathleen Bone, Nathan Kopp, Walter Longo, Bryon D. Johnson, Tyce Kearl, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah

Blood (2024) 144 (Supplement 1): 3459.

https://doi.org/10.1182/blood-2024-205752

Published: 2024

Journal Articles

A More Rapid Initial Decline of BCR::ABL1 Transcripts and Longer Treatment Duration with Improvement of Treatment-Free Remission Rate after Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Sewon Lee, Yeung-Chul Mun, Hongtae Kim, Sung-Ho Park, Semin Lee, Seunghoon Kim, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Yoonsung Lee, Dong-Wook Kim

Blood (2024) 144 (Supplement 1): 1779.

https://doi.org/10.1182/blood-2024-199242

Published: 2024

Journal Articles

Novel Chip-Based Digital Real-Time PCR Platform with Lab on an Array for the Sensitive Detection of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia

Hyun-Woo Song, Sung-Hyun Kim, Young Rok Do, Kyung-Mi Ki, Soo Hyun Kim, Min-Sik Song, Seung-Shick Shin, Dong-Wook Kim

Blood (2024) 144 (Supplement 1): 6596.

https://doi.org/10.1182/blood-2024-206252

Published: 2024

Journal Articles

Retrospective Analysis of Treatment Outcome Differences with and without Autologous Stem Cell Transplantation in Patients with Dialysis-Dependent Multiple Myeloma (DDMM): KMM2304 Study

Myung-Won Lee, Sung-Hoon Jung, Chang-Ki Min, Kihyun Kim, Ho-Young Yhim, Dok Hyun Yoon, Sang Min Lee, Ho-Jin Shin, Jae-Cheol Jo, Jongheon Jung, Yundeok Kim, Jae Hoon Lee, Ji Hyun Lee, Sung-Hyun Kim

Blood (2024) 144 (Supplement 1): 7074.

https://doi.org/10.1182/blood-2024-210665

Published: 2024

Journal Articles

White Blood Cell Count, Neutrophil to Lymphocyte Ratio and Serum Lactate Dehydrogenase Level Associated with Thrombosis Risk Prediction in Essential Thrombocytosis

Yu Been Oh, Young Eun Lee, Ha Jin Lim, Yong Jun Kwon, Yong Jun Choi, Joo Heon Park, Hyun-Jung Choi, Hyun-Woo Choi, Seung-Jung Kee, Soo Hyun Kim, Jong Hee Shin, Myung Geun Shin

Blood (2024) 144 (Supplement 1): 6668.

https://doi.org/10.1182/blood-2024-202880

Published: 2024

Journal Articles

Targeting HMGA1 Epigenetic Regulators and Downstream ETV5 Pathways with Histone Deacetylase Inhibitors in Combination Therapy for Relapsed, Pediatric B-ALL

Linda Resar, Jung-Hyun Kim, Li Z Luo, Katharina Hayer, Camilo Arenas Merizalde, Leslie Cope, Andrei Thomas-Tikhonenko, Sarah K. Tasian

Blood (2024) 144 (Supplement 1): 1361.

https://doi.org/10.1182/blood-2024-211514

Published: 2024

Journal Articles

Intensity-Adjusted Salvage Chemotherapy Plus FLT3-Inhibitor Gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia with Mutated FLT3-ITD/TKD (SAPPHIRE-G)

Hawk Kim, Jae-Sook Ahn, Sung-Hyun Kim, Ho-Young Yhim, Sung-Nam Lim, Yoo Jin Lee, Jeong-Ok Lee, Eun-Ji Choi, Je-Hwan Lee

Blood (2024) 144 (Supplement 1): 2897.

https://doi.org/10.1182/blood-2024-201404

Published: 2024

Journal Articles

Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines

Young Eun Lee, Hye Ran Kim, Ha Jin Lim, Yong Jun Choi, Joo Heon Park, Hyun-Woo Choi, Hyun-Jung Choi, Seung-Jung Kee, Soo Hyun Kim, Jong Hee Shin, Chang Soo Park, Myung Geun Shin

Blood (2023) 142 (Supplement 1): 6034.

https://doi.org/10.1182/blood-2023-180448

Published: 2023

Journal Articles

High Mobility Group A1 Chromatin Regulators Drive Regenerative Capacity during Stress Hematopoiesis through Modulation of TNF-α and Aging Transcriptional Networks

Zanshe Thompson, Li Z Luo, Bowen Wang, Jung-Hyun Kim, Hyunsung Woo, Leslie Cope, Linda Resar

Blood (2023) 142 (Supplement 1): 4050.

https://doi.org/10.1182/blood-2023-189964

Published: 2023

Journal Articles

Red Blood Cell Transfusion Dependence Is Associated with Greater Healthcare Resource Utilization, Higher Medical Cost, and Poorer Prognosis in Patients with Lower-Risk Myelodysplastic Syndromes: A 28-Year Retrospective Observation Study Result

Jun Ho Jang, Ji-Hyun Kim, Kyungah Lee, Eugene Kim, Hyojin Kim, Fangyuan Wang

Blood (2023) 142 (Supplement 1): 1869.

https://doi.org/10.1182/blood-2023-173351

Published: 2023

Journal Articles

A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 2096.

https://doi.org/10.1182/blood-2023-189369

Published: 2023

Journal Articles

Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study)

Blood (2023) 142 (Supplement 1): 6675.

https://doi.org/10.1182/blood-2023-174439

Published: 2023

Journal Articles

Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results

Silvia Park, Sung-Soo Park, Byoung Sik Cho, Sungwon Lim, Kwan Hyun Kim, Gyucheol Choi, Seunghyeok Ham, Seongjoon Lee, Sesun Park, Gunjae Lee, Junyoung Lee, Edward Song, Jamin Koo, Heeje Kim

Blood (2023) 142 (Supplement 1): 1523.

https://doi.org/10.1182/blood-2023-183056

Published: 2023

Journal Articles

Single Cell Transcriptomics Reveal That HMGA1 Chromatin Regulators Drive Transcriptional Networks Involved in Megakaryocyte Expansion, Platelet Activation, and Interferon Signaling in JAK2 V617F Myeloproliferative Neoplasms

Zanshe Thompson, Li Z Luo, Liping Li, Bowen Wang, Jung-Hyun Kim, Hyunsung Woo, Bailey West, Anandi Krishnan, Leslie Cope, Alison R. Moliterno, Jerry L. Spivak, Linda Resar

Blood (2023) 142 (Supplement 1): 3145.

https://doi.org/10.1182/blood-2023-190323

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Tumor-Primed CD3 + CD56 + natural Killer T-like Cells As an Efficient Novel Cell Therapy for Relapsed/Refractory Multiple Myeloma

HMGA1 Chromatin Regulators Disrupt 3D Genome Architecture and Chromatin Looping to Repress MHC II Genes and Drive Immune Evasion during MPN Progression

Gut Microbiome Composition As a Prognostic Marker in CD19-Targeting CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

High Mobility Group A1 (HMGA1) Chromatin Regulators Maintain Quiescent, Regenerative HSC By Repressing IGF1 Networks That Promote Stem Cell Aging

Serial Next-Generation Sequencing for Detection of Germline Predisposition in Acute Myeloid Leukemia

The Impact of Multiple Myeloma on Care Partner Well-Being, Work Productivity, and Resource Use in the United States and Western Europe

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

A More Rapid Initial Decline of BCR::ABL1 Transcripts and Longer Treatment Duration with Improvement of Treatment-Free Remission Rate after Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Novel Chip-Based Digital Real-Time PCR Platform with Lab on an Array for the Sensitive Detection of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia

Retrospective Analysis of Treatment Outcome Differences with and without Autologous Stem Cell Transplantation in Patients with Dialysis-Dependent Multiple Myeloma (DDMM): KMM2304 Study

White Blood Cell Count, Neutrophil to Lymphocyte Ratio and Serum Lactate Dehydrogenase Level Associated with Thrombosis Risk Prediction in Essential Thrombocytosis

Targeting HMGA1 Epigenetic Regulators and Downstream ETV5 Pathways with Histone Deacetylase Inhibitors in Combination Therapy for Relapsed, Pediatric B-ALL

Intensity-Adjusted Salvage Chemotherapy Plus FLT3-Inhibitor Gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia with Mutated FLT3-ITD/TKD (SAPPHIRE-G)

Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines

High Mobility Group A1 Chromatin Regulators Drive Regenerative Capacity during Stress Hematopoiesis through Modulation of TNF-α and Aging Transcriptional Networks

Red Blood Cell Transfusion Dependence Is Associated with Greater Healthcare Resource Utilization, Higher Medical Cost, and Poorer Prognosis in Patients with Lower-Risk Myelodysplastic Syndromes: A 28-Year Retrospective Observation Study Result

A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study)

Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results

Single Cell Transcriptomics Reveal That HMGA1 Chromatin Regulators Drive Transcriptional Networks Involved in Megakaryocyte Expansion, Platelet Activation, and Interferon Signaling in JAK2 V617F Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only